학술논문
Time to negative PCR conversion amongst high-risk patients with mild-to-moderate Omicron BA.1 and BA.2 COVID-19 treated with sotrovimab or nirmatrelvir
Document Type
Article
Author
Martin-Blondel, G.; Gaube, G.; Liblau, R.; Marcelin, A.-G.; Soulié, C.; Zafilaza, K.; Kaisaridi, S.; Lusivika-Nzinga, C.; Dorival, C.; Carrat, F.; Nailler, L.; Boston, A.; Ronchetti, A.-M.; Melenotte, C.; Cabié, A.; Choquet, C.; Trinh-Duc, A.; Lacombe, K.; Coustillères, F.; Pourcher, V.; Martellosio, J.-P.; Peiffer-Smadja, N.; Chauveau, M.; Housset, P.; Piroth, L.; Devaux, M.; Pialoux, G.; Martin, A.; Dubee, V.; Frey, J.; Le Bot, A.; Cazanave, C.; Petua, P.; Yordanov, Y.
Source
In: Clinical Microbiology and Infection . (Clinical Microbiology and Infection, April 2023, 29(4):543.e5-543.e9)
Subject
Language
English
ISSN
14690691
1198743X
1198743X